Literature DB >> 28537529

A Versatile Protocol for Studying Calvarial Bone Defect Healing in a Mouse Model.

Rebekah M Samsonraj1, Amel Dudakovic1, Pengfei Zan1, Oksana Pichurin1, Simon M Cool2,3, Andre J van Wijnen1,4,5.   

Abstract

Animal models are vital tools for the preclinical development and testing of therapies aimed at providing solutions for several musculoskeletal disorders. For bone tissue engineering strategies addressing nonunion conditions, rodent models are particularly useful for studying bone healing in a controlled environment. The mouse calvarial defect model permits evaluation of drug, growth factor, or cell transplantation efficacy, together with offering the benefit of utilizing genetic models to study intramembranous bone formation within defect sites. In this study, we describe a detailed methodology for creating calvarial defects in mouse and present our results on bone morphogenetic protein-2-loaded fibrin scaffolds, thus advocating the utility of this functional orthotopic mouse model for the evaluation of therapeutic interventions (such as growth factors or cells) intended for successful bone regeneration therapies.

Entities:  

Keywords:  animal model; bone regeneration; calvaria; calvarial defect; mouse/mice

Mesh:

Year:  2017        PMID: 28537529      PMCID: PMC5689119          DOI: 10.1089/ten.TEC.2017.0205

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  21 in total

1.  Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2.

Authors:  Gajadhar Bhakta; Bina Rai; Zophia X H Lim; James H Hui; Gary S Stein; Andre J van Wijnen; Victor Nurcombe; Glenn D Prestwich; Simon M Cool
Journal:  Biomaterials       Date:  2012-06-09       Impact factor: 12.479

2.  Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow.

Authors:  Torben Helledie; Christian Dombrowski; Bina Rai; Zophia X H Lim; Ian Lee Hock Hin; David A Rider; Gary S Stein; Wanjin Hong; Andre J van Wijnen; James H Hui; Victor Nurcombe; Simon M Cool
Journal:  Stem Cells Dev       Date:  2012-01-18       Impact factor: 3.272

3.  Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds.

Authors:  Bina Rai; Jane L Lin; Zophia X H Lim; Robert E Guldberg; Dietmar W Hutmacher; Simon M Cool
Journal:  Biomaterials       Date:  2010-08-04       Impact factor: 12.479

4.  Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.

Authors:  M H Lee; A Javed; H J Kim; H I Shin; S Gutierrez; J Y Choi; V Rosen; J L Stein; A J van Wijnen; G S Stein; J B Lian; H M Ryoo
Journal:  J Cell Biochem       Date:  1999-04-01       Impact factor: 4.429

5.  Induction of fully stabilized cortical bone defects to study intramembranous bone regeneration.

Authors:  Meghan E McGee-Lawrence; David F Razidlo
Journal:  Methods Mol Biol       Date:  2015

6.  Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.

Authors:  Amel Dudakovic; Emily T Camilleri; Fuhua Xu; Scott M Riester; Meghan E McGee-Lawrence; Elizabeth W Bradley; Christopher R Paradise; Eric A Lewallen; Roman Thaler; David R Deyle; A Noelle Larson; David G Lewallen; Allan B Dietz; Gary S Stein; Martin A Montecino; Jennifer J Westendorf; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

7.  The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation.

Authors:  Gajadhar Bhakta; Zophia X H Lim; Bina Rai; Tingxuan Lin; James H Hui; Glenn D Prestwich; Andre J van Wijnen; Victor Nurcombe; Simon M Cool
Journal:  Acta Biomater       Date:  2013-07-19       Impact factor: 8.947

8.  Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial model.

Authors:  Maria Ann Woodruff; Subha Narayan Rath; Evelyn Susanto; Larisa M Haupt; Dietmar W Hutmacher; Victor Nurcombe; Simon M Cool
Journal:  J Mol Histol       Date:  2007-09-12       Impact factor: 3.156

9.  Bone regeneration in calvarial defects in a rat model by implantation of human bone marrow-derived mesenchymal stromal cell spheroids.

Authors:  Hideyuki Suenaga; Katsuko S Furukawa; Yukako Suzuki; Tsuyoshi Takato; Takashi Ushida
Journal:  J Mater Sci Mater Med       Date:  2015-10-08       Impact factor: 3.896

10.  Peptide drugs accelerate BMP-2-induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling.

Authors:  Yasutaka Sugamori; Setsuko Mise-Omata; Chizuko Maeda; Shigeki Aoki; Yasuhiko Tabata; Ramachandran Murali; Hisataka Yasuda; Nobuyuki Udagawa; Hiroshi Suzuki; Masashi Honma; Kazuhiro Aoki
Journal:  Bioessays       Date:  2016-06-27       Impact factor: 4.345

View more
  7 in total

1.  Osteogenic Effect of Fisetin Doping in Bioactive Glass/Poly(caprolactone) Hybrid Scaffolds.

Authors:  Henri Granel; Cédric Bossard; Anne-Margaux Collignon; Fabien Wauquier; Julie Lesieur; Gael Y Rochefort; Edouard Jallot; Jonathan Lao; Yohann Wittrant
Journal:  ACS Omega       Date:  2022-06-21

2.  Fibrin glue mediated delivery of bone anabolic reagents to enhance healing of tendon to bone.

Authors:  Endre Soreide; Janet M Denbeigh; Eric A Lewallen; Rebekah M Samsonraj; Lawrence J Berglund; Amel Dudakovic; Simon M Cool; Lars Nordsletten; Sanjeev Kakar; Andre J van Wijnen
Journal:  J Cell Biochem       Date:  2018-03-25       Impact factor: 4.429

3.  Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2.

Authors:  Amel Dudakovic; Rebekah M Samsonraj; Christopher R Paradise; Catalina Galeano-Garces; Merel O Mol; Daniela Galeano-Garces; Pengfei Zan; M Lizeth Galvan; Mario Hevesi; Oksana Pichurin; Roman Thaler; Dana L Begun; Peter Kloen; Marcel Karperien; A Noelle Larson; Jennifer J Westendorf; Simon M Cool; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2020-04-24       Impact factor: 5.157

4.  Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice.

Authors:  Amel Dudakovic; Emily T Camilleri; Christopher R Paradise; Rebekah M Samsonraj; Martina Gluscevic; Carlo Alberto Paggi; Dana L Begun; Farzaneh Khani; Oksana Pichurin; Farah S Ahmed; Ranya Elsayed; Mohammed Elsalanty; Meghan E McGee-Lawrence; Marcel Karperien; Scott M Riester; Roman Thaler; Jennifer J Westendorf; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2018-06-13       Impact factor: 5.157

5.  Activation of creER recombinase in the mouse calvaria induces local recombination without effects on distant skeletal segments.

Authors:  Jue Hou; Charles P Lin; Giuseppe Intini
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

Review 6.  Clinically relevant preclinical animal models for testing novel cranio-maxillofacial bone 3D-printed biomaterials.

Authors:  Luan P Hatt; Keith Thompson; Jill A Helms; Martin J Stoddart; Angela R Armiento
Journal:  Clin Transl Med       Date:  2022-02

Review 7.  Therapeutic Potential of Dental Pulp Stem Cells According to Different Transplant Types.

Authors:  Tomasz Staniowski; Anna Zawadzka-Knefel; Katarzyna Skośkiewicz-Malinowska
Journal:  Molecules       Date:  2021-12-07       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.